The-174G/C variant of IL6 as risk factor for mortality and technique failure in a large cohort of peritoneal dialysis patients

Nephrology Dialysis Transplantation

Volumn 27, Issue 9, 2012, Pages 3516-3523

  Verduijn, Marion ^a   Maréchal, Céline ^b   Coester, Annemieke M ^c   Sampimon, Denise E ^c   Boeschoten, Els W ^d   Dekker, Friedo W ^a   Goffin, Eric ^b   Krediet, Raymond T ^c   Devuyst, Olivier ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d Hans Mak Institute   (Netherlands)

Author keywords

IL 6; mortality; peritoneal dialysis; polymorphism

Indexed keywords

CYTOSINE; GUANOSINE; INTERLEUKIN 6;

ADULT; ALLELE; ARTICLE; CAUCASIAN; COHORT ANALYSIS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK FACTOR; SURVIVAL;

FEMALE; FOLLOW-UP STUDIES; GENOTYPE; GLOMERULAR FILTRATION RATE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SURVIVAL RATE; TREATMENT FAILURE;

EID: 84865715384     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs128     Document Type: Article

References (37)

1. Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res 2002; 4: S233-S242.
2. Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376.
3. Bologa RM, Levine DM, Parker TS et al. Interleukin-6 predicts hypoalbuminuria, hypocholesterolemia and mortality in hemodialysis patients. Am J Kidney Dis 1998; 31: 107-114.
4. Pecoits-Filho R, Boby P, Lindholm B et al. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002; 17: 1684-1688.
5. Lui Y, Berthier-Schaad Y, Fallin MD et al. IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol 2006; 17: 863-870.
6. Aker S, Bantis C, Reis P et al. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients. Nephrol Dial Transplant 2009; 24: 2847-2851.
7. Brimble KS, Walker M, Margetts PJ et al. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 2006; 17: 2591-2598.
8. Gillerot G, Goffin E, Michel C et al. Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 2005; 67: 2477-2487.
9. Rodrigues AS, Almeida M, Fonseca I et al. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation. Nephrol Dial Transplant 2006; 21: 763-769.
10. Van Dijk PC, Jager KJ, de Charro F et al. Renal replacement therapy in Europe: the results of a collaborative effort by the ERAEDTA registry and six national or regional registries. Nephrol Dial Transplant 2001; 16: 1120-1129.
11. Gillerot G, Debaix H, Devuyst O. Genotyping: a new application for the spent dialysate in peritoneal dialysis. Nephrol Dial Transplant 2004; 19: 1298-1301.
12. Southern DA, Faris PD, Brant R et al. Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol 2006; 59: 1110-1114.
13. Verduijn M, Grootendorst DC, Dekker FW et al. The analysis of competing events like cause-specific mortality-beware of the Kaplan-Meier method. Nephrol Dial Transplant 2011; 26: 56-61.
14. Ridker PM, Rifai N, Stampfer MJ et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767-1772.
15. Harris TB, Ferrucci L, Tracy RP et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106: 506-512.
16. Zemel D, ten Berge RJ, Koomen GC et al. Serum interleukin-6 continuous ambulatory peritoneal dialysis in patients. Nephron 1993; 64: 320-321.
17. Panichi V, Maggiore U, Taccola D et al. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1154-1160.
18. Hurst SM, Wilkinson TS, McLoughlin RM et al. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitement seen during acute inflammation. Immunity 2001; 14: 705-714.
19. Goldman M, Vandenabeele P, Moulart J et al. Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis. Nephron 1990; 56: 277-280.
20. Devuyst O, Margetts PJ, Topley N. The pathophysiology of the peritoneal membrane. J Am Soc Nephrol 2010; 21: 1077-1085.
21. Zemel D, Koomen GC, Hart AA et al. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993; 122: 686-696.
22. Pecoits-Filho R, Araeo MR, Lindholm B et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17: 1480-1486.
23. Zemel D, ten Berge RJ, Struijk DG et al. Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane. Clin Nephrol 1992; 37: 97-103.
24. Oh KH, Jung JY, Yoon MO et al. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients. Nephrol Dial Transplant 2010; 25: 1639-1646.
25. Rodrigues AS, Martins M, Korevaar JC et al. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters. Am J Nephrol 2007; 27: 84-91.
26. Cho JH, Hur IK, Kim CD et al. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study. Nephrol Dial Transplant 2010; 25: 1964-1973.
27. Brull DJ, Montgomery HE, Sanders J et al. Interleukin-6 gene-174gc and-572gc promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001; 21: 1458-1463.
28. Jenny NS, Tracy RP, Ogg MS et al. In the elderly, interleukin-6 plasma levels and the-174GC polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 2002; 22: 2066-2071.
29. Vickers MA, Green FR, Terry C et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002; 53: 1029-1034.
30. Wypasek E, Undas A, Sniezek-Maciejewska M et al. The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174GC gene polymorphism. Ann Clin Biochem 2010; 47: 343-349.
31. Balakrishnan VS, Guo D, Rao M et al. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 2004; 65: 1449-1460.
32. Lim WH, Boudville N, McDonald SP et al. Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Nephrol Dial Transplant 2011; 26: 3366-3372.
33. Tangri N, Ansell D, Naimark D. Determining factors that predict technique survival on peritoneal dialysis: application of regression and artificial neural network methods. Nephron Clin Pract 2011; 118: c93-c100.
34. Humphries SE, Luong LA, Ogg MS et al. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001; 22: 2243-2252.
35. Hulkkonen J, Lehtimi T, Mononen N et al. Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: the Cardiovascular Risk in Young Finns Study. Atherosclerosis 2009; 203: 454-458.
36. Losito A, Kalidas K, Santoni S et al. Association of interleukin-6-174 G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients. Kidney Int 2003; 64: 616-622.
37. Balakrishnan VS, Rao M. Genetics and reverse epidemiology among patients on chronic hemodialysis. Semin Dial 2007; 20: 570-576.